Taro Pharmaceutical Indus Stock (NYSE: TARO) stock price, news, charts, stock research, profile.
Open | $42.340 |
Close | $42.400 |
Volume / Avg. | 27.112K / 47.255K |
Day Range | 42.230 - 42.490 |
52 Wk Range | 24.390 - 45.760 |
Market Cap | $1.594B |
P/E Ratio | 34.820 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 57 |
Short Interest | 0.49% |
Days to Cover | 1.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Taro Pharmaceutical Indus (NYSE: TARO) through any online brokerage.
There are no as such competitors for Taro Pharmaceutical Indus.
The latest price target for Taro Pharmaceutical Indus (NYSE: TARO) was reported by HC Wainwright & Co. on Thursday, January 18, 2024. The analyst firm set a price target for 43.00 expecting TARO to rise to within 12 months (a possible 1.42% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Taro Pharmaceutical Indus (NYSE: TARO) is $42.4 last updated April 26, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $12.81 per share of Class A Common Stock. The quarterly cash dividend was payable on December 28, 2018 to stockholders of record on December 10, 2018.
Taro Pharmaceutical Indus’s Q1 earnings are confirmed for Wednesday, July 24, 2024.
There is no upcoming split for Taro Pharmaceutical Indus.
Taro Pharmaceutical Indus is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.